Arytmogen høyre ventrikkel kardiomyopati (ARVC)
ARVC er en tilstand hvor noen muskelceller i hjertet erstattes av bindevev- og fettceller. Dette reduserer pumpekraften og kan påvirke hjertets ledningssystem. Sykdommen kan være arvelig.
Sist revidert:
Del pasientinformasjon
Den ligger åpent tilgjengelig på NHI.no sammen annen relevant informasjon
https://nhi.no/sykdommer/hjertekar/hjertearytmier/arytmogen-hoyre-ventrikkel-cardiomyopati/Hva er ARVC?
Hyppighet
Symptomer
Diagnosen
Behandling
Egenbehandling
Hjertestarter
Medikamentell behandling
Annen behandling
Prognose
Vil du vite mer?
Kilder
Referanser
Dette dokumentet er basert på det profesjonelle dokumentet Arytmogen høyre ventrikkel kardiomyopati. Referanselisten for dette dokumentet vises nedenfor.
- Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician 2006; 73: 1391-8. American Family Physician
- Brieler J, Breeden MA, Tucker J. Cardiomyopathy: An Overview. Am Fam Physician. 2017;96(10):640-646. PubMed
- Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793-2867. PubMed
- Corrado D, Link MS, Calkins H. Arrhythmogenic Right Ventricular Cardiomyopathy. N Engl J Med. 2017;376(1):61-72. PubMed
- Firat Duru, Richard N W Hauer, Multiple facets of arrhythmogenic cardiomyopathy: the Fuwai classification of a unique disease based on clinical features, histopathology, and genotype, European Heart Journal, Volume 40, Issue 21, 1 June 2019, Pages 1704–1706. PMID: 31152552 PubMed
- Marcus FI, Fontaine GH, Guiraudon G, Frank R, Laurenceau JL, Malergue C, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982; 65: 384-98. Circulation
- Murray B. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a review of molecular and clinical literature. J Genet Couns. 2012;21(4):494–504.
- Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289–1300.
- Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806–814.
- Corrado D, Basso C, Schiavon M, Thiene G. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 1998; 339: 364. New England Journal of Medicine
- te Riele AS, James CA, Groeneweg JA, et al. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J 2016; 37: 755. pmid:26314686 PubMed
- Te Riele AS, James CA, Philips B, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol 2013; 24: 1311-20. pmid:23889974 PubMed
- Marcus FL, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121: 1533. Circulation
- Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm 2019; 16:e301. PubMed
- McKenna WJ. Arrhythmogenic right ventricular cardiomyopathy: Diagnostic evaluation and diagnosis. UpToDate, last updated Dec 16, 2019. UpToDate
- Fontaine G, Fontaliran F, Frank R. Arrhythmogenic right ventricular cardiomyopathies: clinical forms and main differential diagnoses. Circulation 1998; 97: 1532-5. Circulation
- Corrado D, Wichter T, Link MS, et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement. Eur Heart J. 2015;36(46):3227–3237. PMID: 26216920 PubMed
- Maron BJ, Zipes DP, Kovacs RJ. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Preamble, principles, and general considerations: A scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015; 66: 2343-9. pmid:26542655 PubMed
- Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: e247. PubMed
- Corrado D, Calkins H, Link MS, et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation 2010; 122: 1144. Circulation
- McKenna WJ. Treatment and prognosis of arrhythmogenic right ventricular cardiomyopathy. UpToDate, last updated Aug 03, 2015 . UpToDate
- McKenna WJ. Arrhythmogenic right ventricular cardiomyopathy: Treatment and prognosis. UpToDate, last updated Nov 11, 2021. UpToDate
- Groeneweg JA, Bhonsale A, James CA, et al. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ Cardiovasc Genet 2015; 8: 437-46. pmid:25820315 PubMed